Articles from Investor Brand Network

A recent study from the University of Arizona Health Sciences suggests that terpenes found in the marijuana plant may offer a new way to manage post-surgical and fibromyalgia pain. The study expands on prior research conducted by Comprehensive Center for Pain and Addiction member Dr. John Streicher, who previously explored the pain-relieving properties of terpenes in cases of inflammation and nerve pain caused by chemotherapy.

Thumzup (NASDAQ: TZUP), a growing force in social media branding and programmatic marketing, announced the repurchase of $126,507 of its common stock as part of its previously approved $1 million buyback program. The company views the repurchase as a strategic move to enhance shareholder value and reinforce confidence in its growth trajectory. CEO Robert Steele highlighted the buyback as a demonstration of Thumzup’s commitment to capital efficiency and long-term value creation. The company has also reported surpassing 700 advertisers on its platform, with a compound annual growth rate exceeding 200%.

A recent report has revealed that Chinese automotive giant BYD is considering establishing an electric vehicle (EV) assembly plant in Germany . According to Reuters, the Shenzhen, Guangdong-based company is debating whether to construct a third new energy vehicle (NEV) plant in Europe.

A few weeks ago, the European Commission introduced measures aimed at streamlining and simplifying sustainability reporting for businesses. The measures housed under the Omnibus package address key regulatory frameworks, including the Corporate Sustainability Due Diligence Directive (CSDDD), the Corporate Sustainability Reporting Directive (CSRD), the EU Taxonomy and the Carbon Border Adjustment Mechanism (CBAM).

Rare-earth elements (REEs) have dominated the news lately after the explosive meeting between President Trump and Ukraine’s president Zelenskyy resulted in a minerals deal falling through between the two countries. However, America needs to be more concerned about expected supply shortages of copper .

Walter Reed National Military Medical Center officials confirmed they are awaiting a $4.9m grant to study MDMA with a focus on troops on active duty. The money will be provided by the U.S. Department of Defense (DOD).

California recently extended a ban on intoxicating hemp products with THC that was set to expire before the end of March. This comes just months after the ban went into effect following legislators’ failure to approve a measure that would’ve regulated these products.

Environmental, Social and Governance (ESG) frameworks have grown in importance these last couple of years as sustainability becomes a more significant concern for consumers, investors and corporations alike.

Apple (NASDAQ: AAPL) has lost a key executive from its health division, as Dr. Ricky Bloomfield, formerly the Clinical and Health Informatics Lead, departs to join Oura as its Chief Medical Officer. Bloomfield played a critical role in shaping Apple’s health strategy, including its push into digital health records and wearable health tracking. His move to Oura, a company specializing in smart rings for health monitoring, signals growing competition in the wearable health-tech space, with some analysts seeing it as a potential shift in consumer interest toward ring-based health tracking over smartwatches.

Cannabis advocates in Ohio are expressing frustration with state lawmakers for pushing legislation to modify the state’s marijuana laws. Since voters approved a measure to legalize recreational cannabis in November 2023, GOP leaders have been working to impose more restrictive policies.

New research that appeared in the journal Oncotarget has opened the door to a new way to approach the treatment of oral ulcers induced by chemotherapy. This debilitating and painful side effect of cancer treatment lowers the quality of life of patients undergoing chemotherapy, but oral mucositis remains an unmet medical need.

Jensen Huang, Nvidia’s CEO, will defend the company’s dominance in the AI chip market amid growing concerns about costs during the upcoming firm’s annual developer conference. As the industry leader in high-performance chips, Nvidia has benefited from the surge in AI demand, but competition and shifting market trends are putting pressure on its position.

Match Group (NASDAQ: MTCH), s confronting a proxy challenge from hedge fund Anson Funds, which plans to nominate directors to the company’s 10-member board. Anson, holding approximately 0.6% of Match Group’s shares as of December, has been advocating for over a year for the parent company of Tinder, Hinge, and OkCupid to reassess capital allocation, reduce costs, and evaluate its MG Asia business. The hedge fund has also expressed concerns about corporate governance and executive turnover, noting that Match Group has had four CEOs in five years.

The open enrollment period for Medicare Advantage (MA) is on until the end of March. If you have been thinking about changing your medical plan, time is running out and you need to act fast. However, your decision shouldn’t be a rushed one as many considerations need to be weighed before you make any decisions.

Russia has turned to crypto for oil transactions with India and China to bypass Western sanctions, per sources familiar with the matter.

Web3 is creating new job opportunities in blockchain, cryptocurrency, and decentralized finance. Many people are excited about working in this fast-growing field. However, scammers are also taking advantage of job seekers by offering fake jobs . These scams can lead to financial losses and stolen personal information.

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with a portfolio of over 97 issued and pending patents, will host a corporate update call to present its fourth quarter and full-year 2024 financial results. The conference call is scheduled for Monday, March 24, 2025, at 4:30 p.m. Eastern Time. Participating executives include Founder and Executive Chairman Rani Kohen, President Steve Schmidt, Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The call will provide insights into SKYX’s latest advancements, market position, and financial performance.

Walk-in Dermatology is transforming patient access to dermatological care by combining the convenience of urgent care with the expertise of traditional dermatology. In the latest Bell2Bell podcast, Steven Dresner, CEO of Walk-in Dermatology, discusses the company’s mission to provide same-day, high-quality dermatology services without the long wait times typical of traditional practices. Dresner explains how the model serves patients who need immediate care for conditions like rashes or acne but face delays in scheduling with conventional dermatologists.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company, has published a peer-reviewed study highlighting a potential breakthrough in addressing drug resistance to EGFR-targeted therapies for non-small cell lung cancer (NSCLC). The study, published in Drug Resistance Updates, identifies CD105 (endoglin) as a key factor in mediating resistance to osimertinib, a frontline treatment for EGFR-mutant NSCLC. Preclinical models demonstrated that targeting CD105 with ENV105 (carotuximab), a CD105-neutralizing antibody, restored treatment sensitivity, suggesting a novel combination therapy strategy to overcome drug resistance. Kairos Pharma is currently evaluating this approach in clinical trials.

Fifty 1 Labs (OTC: FITY) a holding company in the health, wellness, and biotech sectors, has acquired Genetic Networks LLC, a biotech firm founded by Dr. Gennaro D’Urso, for $10 million in common shares. As part of the deal, Dr. D’Urso has been appointed CEO and Chairman, while Brandon Spikes remains President and Director. Genetic Networks, known for its GeneScape platform, is actively negotiating multi-million dollar contracts with the U.S. Department of Defense to develop biothreat countermeasures. The acquisition enhances FITY’s biotech capabilities, positioning it for rapid growth in personalized medicine, drug repurposing, and biodefense solutions.

Adageis, a healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations, is set to exceed its Q1 2025 growth expectations as its AI-powered platform continues to gain traction in the healthcare sector. The company now covers more than 250,000 patient lives, a sharp increase from its previously reported 150,000. This growth highlights a rising demand for technology that helps providers successfully transition from fee-for-service models to value-based care.

The European Union (EU) is becoming increasingly reliant on wind energy as it transitions from fossil fuels to cleaner energy sources. Like solar power, wind energy has taken center stage as one of the primary renewable alternatives to fossil fuels such as oil, coal, and natural gas, thanks to its abundance across the EU.

The crypto industry recently faced intense scrutiny from the SEC but ultimately emerged victorious. Now, key figures in the crypto world are turning their attention to the regulator, pushing back in various ways.

Across the world, more people are choosing Sport Utility Vehicles (SUVs) over smaller cars. This trend continues even though experts and environmental groups warn about the harmful effects of SUVs on the climate. Many believed that the future of transportation would be small, energy-efficient electric vehicles (EVs). However, SUVs remain the top choice for car buyers.

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicating recombinant virus vaccine designed to protect against mpox. The company reports that TNX-801 has demonstrated single-dose immunity and superior tolerability compared to 20th-century vaccinia vaccines in animal studies. As a new strain of mpox, Clade I, spreads globally—including recent cases in the U.S.—health officials are seeking more effective prevention methods. Tonix believes TNX-801 aligns with the World Health Organization’s criteria for durable, single-dose vaccines that can be administered without special equipment.

A contentious bipartisan measure aimed at addressing the high potency of cannabis in Colorado was withdrawn by its sponsors during a committee hearing. The measure faced immediate backlash, particularly over proposed regulations on specific edibles and age restrictions.

Adageis was featured in a recent article that discussed the company’s positioning as healthcare shifts toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. “While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures that can be difficult to navigate,” the article reads.

Thumzup (NASDAQ: TZUP) is leveraging its proprietary social media marketing platform, AdTech, which drives influencers to catapult the effectiveness of small-business advertising. Having achieved a growth rate of over 200% CAGR, Thumzup now serves more than 700 clients, with projections to exceed 1,000 by the next financial quarter. As social media marketing continues to grow, Thumzup’s innovative platform allows brands to easily customize campaigns and incentivizes influencer engagement with direct cash rewards, making it a disruptive force in the industry. CEO Robert Steele attributed the company’s growth as a testament to the effectiveness of its model, stating, “Our rapid growth to more than 700 advertisers, up from around 200 this time last year, is confirmation of the effectiveness of our disruptive advertising model.”

The rise of Web3 is revolutionizing how we interact with the internet, shifting from centralized platforms to decentralized systems that prioritize user ownership and transparency. As this new digital landscape evolves, companies are looking for skilled professionals to build, manage, and enhance decentralized applications (DApps), smart contracts, and blockchain ecosystems.

A Florida couple has been accused of using an online dating app to lure, torture, and kill a teenage girl. The couple allegedly used dating app Grindr to lure 16-year-old Miranda Corsette to their home in St. Petersburg for a meetup in late February. After torturing and murdering the girl, the St. Petersburg Police Department says, the couple discarded her dismembered remains in a dumpster.

Authentic Holdings (OTC: AHRO) announced its agreement to acquire Goliath Motion Pictures Entertainment in an $11 million equity-based transaction. The acquisition will bring over 40,000 titles, including award-winning shows and films such as In Living Color, The Cosby Show , and Open Range , under Authentic Holdings’ ownership. The deal is structured as Convertible Preferred Stock, with conversion restrictions for three years to minimize shareholder dilution. Management expects the acquisition to strengthen Maybacks Global Entertainment’s market position, increase advertising revenue, and support expansion into all major U.S. markets. An 8-K will be filed with the SEC upon completion.

Datavault AI (NASDAQ: DVLT) announced that Realtek will showcase a new set-top box software development kit (SDK) featuring WiSA E technology at the Convergence India Expo from March 19-21, 2025. The SDK delivers 5.1 spatial audio without added transmitter hardware costs, offering manufacturers a cost-effective way to enhance home entertainment experiences. Datavault AI’s collaboration with Realtek aligns with India’s push for AI and blockchain integration, positioning its patented Data Vault® and ADIO® solutions for enterprise adoption in government, finance, and smart infrastructure. With India’s AI market projected to reach $17 billion by 2027, Datavault AI sees this partnership as a significant opportunity for expansion and data monetization.

Standard Lithium (NYSE American: SLI) announced the appointment of Karen G. Narwold as an independent director to its board. Narwold brings over 30 years of leadership experience in manufacturing and chemicals, most recently serving as Chief Administrative Officer, General Counsel, and Corporate Secretary at Albemarle Corporation. Her expertise in legal, governance, regulatory, and operational matters is expected to support Standard Lithium’s development of lithium projects in the Smackover formation. Narwold also serves on the board of Ingevity Corporation and chairs its Sustainability & Safety Committee.

Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by approximately 50% in a prostate cancer animal model. The study demonstrated that Telomir-1 actively suppresses cancer growth while protecting against chemotherapy-induced toxicity when combined with Paclitaxel. Contrary to concerns that telomere-elongating drugs may promote cancer, Telomir-1 selectively benefited healthy cells while inhibiting tumor development. The company is advancing Telomir-1 toward clinical development for oncology and age-related diseases, aiming to submit an Investigational New Drug (IND) application by the end of 2025.

Oragenics (NYSE American: OGEN) announced the filing of its Annual Report on Form 10-K for the year ended Dec. 31, 2024, with the U.S. Securities and Exchange Commission on March 14, 2025. The company’s audited financial statements received an unqualified audit opinion, though an explanatory paragraph raised concerns about its ability to continue as a going concern. Oragenics remains focused on advancing its pipeline of treatments for concussion and brain-related health conditions while pursuing strategic opportunities to ensure long-term growth. Further details are available in Footnote 1 of the financial statements.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced that its common shares have been included in several major stock indices, including the NYSE Arca Gold Miners Index (GDX), MVIS Global Junior Gold Miners Index (GDXJ), S&P/TSX Composite Index (GSPTSE), and iShares MSCI Canada ETF (EWC). President and CEO Louis-Pierre Gignac stated that the inclusions reflect the company’s commitment to executing its self-perform approach and advancing its gold projects, including the Tocantinzinho Gold Mine. These index additions are expected to enhance trading liquidity and attract institutional investment. The rebalancing for GDX, GDXJ, and GSPTSE is set for March 21, 2025, while EWC was rebalanced on Feb. 28, 2025.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has released new data showing that its lead drug candidate, CNM-Au8, significantly extends survival in patients with ALS. The findings were derived from a cross-regimen post hoc analysis of long-term survival in HEALEY ALS Platform Trial participants ( https://ibn.fm/EgWeb ).

Tonix Pharmaceuticals (NASDAQ: TNXP) announced its fourth-quarter and full-year 2024 financial results, alongside key operational updates. The company highlighted preparations for the potential commercial launch of TNX-102 SL for fibromyalgia in Q4 2025, pending FDA approval with a PDUFA date set for Aug. 15, 2025. Tonix remains debt-free, with cash resources projected to support operations into early 2026. The company also reported progress across its pipeline, including TNX-1500 for kidney transplant rejection, TNX-801 for mpox and smallpox, and TNX-1300 for cocaine intoxication. For Q4 2024, net product revenue reached $2.6 million, while the company reported a net loss of $22.1 million. Full-year 2024 net loss was $130 million, with R&D expenses reduced to $40 million from $86.7 million in 2023 due to pipeline prioritization.

The Idaho State Senate has approved a proposed constitutional amendment that would give the legislature sole authority to legalize cannabis and other drugs. The measure, known as House Joint Memorial 4, will be put to a vote in the November 2026 elections.

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases,” reads a recent article. “With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.”

Trump Media & Technology Group (NASDAQ: DJT) has experienced a significant downturn, with its stock price plummeting 50% since President Donald Trump’s inauguration. The shares closed at a five-month low of $19.17 last week, reflecting broader market challenges. ​

Microsoft (NASDAQ: MSFT) has launched Office 2024 Home & Business for both Mac and PC, offering users a lifetime license as an alternative to the subscription-based Microsoft 365. This version includes essential applications such as Word, Excel, PowerPoint, Outlook, and OneNote. Notably, the 2024 edition integrates AI features like Word’s Smart Compose, providing intelligent suggestions to enhance productivity.

President Donald Trump’s administration has finally pulled the plug and halted the federal government’s ongoing efforts to adopt electric vehicles. A series of internal memos obtained by Colorado Public Radio and NPR have revealed that the U.S. General Services Administration (GSA) has suspended electric vehicle orders temporarily, ordered the closure of some EV charging stations, and halted the installation of new electric vehicle charging stations.

Iran has gone into overdrive in its efforts to import gold over the past months as it braces for additional hardships under the new Trump administration, which is promising a regime of “ maximum pressure ” for the Iranian government.

Entrepreneurs in Delaware are growing increasingly frustrated with the state’s slow rollout of recreational cannabis sales. Although Delaware legalized recreational marijuana in 2023 and was expected to launch sales this spring, several obstacles have put the launch on hold.

Elon Musk is reportedly exploring the use of artificial intelligence to manage the United States government, a move that has sparked serious concerns among experts who warn of potential risks and unintended consequences.

Knightscope (NASDAQ: KSCP), a developer of autonomous security robots and AI technologies, has formally submitted public comments to the White House’s AI Action Plan, emphasizing the need for AI-powered security solutions in federal facilities and critical infrastructure. The company’s recommendations include modernizing procurement policies, launching multi-agency pilot programs, and restricting the purchase of autonomous security robots from adversary nations. CEO William Santana Li highlighted the role of AI-driven security in enhancing public safety while reducing costs. Knightscope’s technology aims to strengthen national security by providing continuous situational awareness and acting as a force multiplier for human security personnel.

Brera Holdings (NASDAQ: BREA), an international multi-club ownership company, has announced its sponsorship of “Pepito Day,” a tribute event celebrating the career of Giuseppe “Pepito” Rossi. Set for March 22, 2025, at Stadio Artemio Franchi in Florence, Italy, the event will bring together legendary football figures, including Sir Alex Ferguson, Gabriel Batistuta, Andrea Pirlo, and Giorgio Chiellini. Rossi, a Brera Holdings advisory board member, played a key role in Fiorentina’s history and continues to contribute to the company’s global football operations. The celebration will feature a youth tournament, meet-and-greet sessions, and a star-studded match.

Trillion Energy (CSE: TCF) (OTCQB: TRLEF) has provided an operational update on its SASB offshore gas project in Turkey, highlighting the successful installation of velocity string tubing in six wells to improve production efficiency. The company has also initiated nitrogen injection to stimulate gas output, with positive results confirming the effectiveness of water reduction measures. To sustain long-term production, Trillion has secured a gas lift compressor for the Akcakoca platform, with onshore testing set to begin March 24 before mobilization the following week. Additional pump solutions, including a Progressive Cavity Pump and Electric Submersible Pumps, will further optimize well performance in the coming months.

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) a Swiss-hosted cybersecurity and privacy communications platform, has outlined key strategic initiatives, including the launch of its Sekur Corporate Suite and plans for a potential Nasdaq uplisting. CEO Alain Ghiai highlighted the company’s focus on enterprise security solutions, emphasizing strong revenue potential with an 80% gross margin per dollar sold. Sekur is expanding globally, leveraging Swiss privacy laws to differentiate itself in the $88.8 billion projected secure communications market. The company is finalizing strategic agent agreements to expand its reach and accelerate adoption.

TC BioPharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing allogeneic gamma-delta T cell therapies, is implementing a strategic shift to a decentralized model, outsourcing key functions to contract development and manufacturing organizations (CDMOs). The transition is expected to reduce operational costs by approximately 55% compared to 2024, with estimated annual savings of $4.2 million. As part of this restructuring, the company will reduce its workforce by around 20 employees, primarily in production and quality divisions. CEO Bryan Kobel emphasized that the move positions TC BioPharm for future clinical trials and advancements in cell therapy manufacturing.

Aditxt (NASDAQ: ADTX) through its wholly owned subsidiary Adivir, Inc., is progressing with its planned acquisition of Appili Therapeutics (TSX: APLI; OTCPink: APLIF) under a court-approved plan of arrangement. Appili shareholders have overwhelmingly approved the transaction, and the company has secured all necessary court approvals. The closing remains contingent on Aditxt securing sufficient financing, with an extension granted until March 31, 2025, in exchange for a $250,000 payment. Separately, Appili has applied for up to $117.5 million in U.S. federal funding to support infectious disease treatments, further positioning the company within the critical biopharmaceutical sector.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has confirmed a major milestone in quantum computing, demonstrating quantum computational supremacy on a practical, real-world problem. A newly published, peer-reviewed paper in Science validates that D-Wave’s annealing quantum computer outperformed a state-of-the-art classical supercomputer in simulating quantum dynamics in magnetic materials. The full study, titled “ Beyond-Classical Computation in Quantum Simulation,” is available at https://ibn.fm/VEsx9 .

The European Union (EU) is looking to build a collaboration with two African nations to gain a secure line to the continent’s rich reserves of minerals. With the EU adopting electrification and clean energy, there is a massive need for critical raw materials to be available in countries like the Democratic Republic of Congo (DRC).

Tesla, once the leader in the electric vehicle (EV) industry, is now struggling with falling sales . The situation has led to competitors like BMW to grow their share in the EV market. With a strong lineup of battery-electric vehicles (BEVs), new technology, and a strategy that includes different types of vehicles, BMW is positioning itself as a major player in the EV industry.

Energy Fuels (NYSE American: UUUU) (TSX: EFR) and Chemours (NYSE: CC) have announced a strategic alliance to enhance domestic rare earth and critical mineral supply chains. The collaboration builds on their existing relationship, leveraging Energy Fuels’ rare earth element production and Chemours’ heavy mineral sands mining operations in Florida and Georgia. The companies aim to bolster U.S. production of rare earth elements, titanium, and zirconium, reducing reliance on foreign sources. Executives from both firms, along with government officials, highlighted the agreement’s role in strengthening national security and economic stability.

Germany’s coalition negotiations could become tense as the Christian Democrats (CDU) and Social Democrats (SPD) clash over the country’s marijuana law. The SPD, which championed the legislation last year, considers it a key achievement, while the CDU has always opposed legalization.

McEwen Mining (NYSE: MUX) (TSX: MUX) will host a conference call on March 18, 2025, at 11 a.m. EDT to discuss its fourth-quarter and year-end 2024 financial results. Management will provide updates on financial performance and project developments, followed by a question-and-answer session where participants can engage directly via phone during the webcast.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the year ended December 31, 2024. The company also announced a consolidated cash balance that now exceeds $300 million.

Aditxt (NASDAQ: ADTX), a health innovation platform, provided a corporate update highlighting progress across its subsidiaries and acquisition initiatives. The company remains focused on advancing its autoimmune treatment subsidiary Adimune , precision diagnostics unit Pearsanta , and neurological monitoring subsidiary Adivue , while also pursuing strategic acquisitions, including Appili Therapeutics and Evofem Biosciences. Additionally, Aditxt will launch its Aditxt Weekly Update series on March 21, 2025, featuring CEO Amro Albanna and Evofem CEO Saundra Pelletier, aiming to enhance transparency and investor engagement.

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has announced the addition of Dr. Arthur B. Laffer to its Advisory Board. His strategic input to the company can help develop Brera’s proprietary financial models to optimize player salaries, transfer fees, and overall profitability. In addition, his corporate and political networks could be integral in positioning Brera’s clubs as transatlantic brands, providing exposure to American investors ( https://ibn.fm/J5alM ).

Datavault AI (NASDAQ: DVLT), a leader in AI-driven data valuation and monetization, announced a multi-year commercial and intellectual property partnership with NYIAX, a blockchain-based trading technology company. The collaboration integrates Datavault AI’s Information Data Exchange® and Data Vault® platform with NYIAX’s Nasdaq-powered trading framework to enable seamless, scalable, and secure data monetization. The partnership aims to transform data into a tradeable financial asset through AI-driven valuation, tokenized exchanges, and automated smart contract execution, bridging the gap between data valuation and liquidity.

FingerMotion (NASDAQ: FNGR), a mobile services, data, and technology company, announced its participation in the 37th Annual ROTH Conference, scheduled for March 16-18, 2025, at The Laguna Cliffs Marriott in Dana Point, California. The event will feature 1-on-1 and small group meetings, fireside chats, industry panels, and keynotes, bringing together executives from approximately 450 private and public companies across various growth sectors. FingerMotion’s management team is available for investor meetings through the conference portal.

A new study has found that while all ethnic and racial groups can benefit from using psilocybin, some effects vary depending on the ethnic or racial group that an individual belongs to. More specifically, the mental flexibility and spiritual wellbeing improvements resulting from psilocybin use aren’t as pronounced and don’t persist for long among individuals of color when compared to these same effects in White people.

A new poll has determined that frequent consumers of marijuana like using delivery platforms to order their products. The poll involved 655 respondents and was carried out from February 20 th to 23 rd by Nugg MD, a leading medical cannabis technology platform.

Although data collection and analytics have always been a part of business for decades, data analytics has exploded in recent years. Experts estimate that businesses analyze around 37% to 40% of their data while 97.2% of companies invest in some kind of big data solution to inform their decision-making .

SKYX Platforms (NASDAQ: SKYX), an advanced smart home technology company, reported record fourth-quarter revenue of $23.7 million, continuing its consistent growth throughout 2024. The company also secured an additional $1 million in preferred funding, bringing its total to $12 million. SKYX is expanding its smart plug & play technology across major retail and professional segments, aiming to reach 20,000 homes by the end of Q1 2025. Recent strategic moves include partnerships with Cavco Homes and Forte Developments, a collaboration with Wayfair, and leadership additions to drive e-commerce and product expansion.

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) announced record financial results for 2024, with revenue reaching $1.29 billion, up 26% from 2023, and operating cash flow climbing 37% to $1.03 billion. Adjusted net earnings rose 20% to $640 million. The company exceeded production guidance, delivering 635,000 gold equivalent ounces (GEOs), driven by strong performances at Salobo and Constancia. Wheaton expanded its asset base with four new streaming and royalty agreements and maintains a strong balance sheet with $818 million in cash and no debt. The company also increased its quarterly dividend by 6.5% to $0.165 per share. Looking ahead, Wheaton forecasts a 40% increase in annual production over five years, reaching 870,000 GEOs by 2029.

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and contract development and manufacturing (CDMO) services, announced its participation in the BIO-Europe Spring 2025 conference from March 17-19 in Milan, Italy. The company’s leadership will meet with potential pharmaceutical partners, prospective CDMO clients, and institutional investors to showcase its innovative NanoAb pipeline and biologics manufacturing capabilities. Scinai will also exhibit its CDMO services at booth #22.

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (REE), and heavy mineral sands, announced the signing of a strategic Memorandum of Understanding (MOU) with South Korea-based POSCO International Corporation. The agreement outlines a collaboration aimed at establishing a new non-China REE supply chain for electric vehicle (EV) and hybrid EV drivetrains for automakers in the U.S., E.U., Japan, and South Korea. Initial samples of Energy Fuels’ neodymium-praseodymium (NdPr) oxide from its White Mesa Mill in Utah have met POSCO’s specifications. If validated, Energy Fuels could supply NdPr oxide for mass production later this year, supporting the manufacturing of high-performance REE magnets.

Minnesota is among several states testing a new device that detects THC in saliva, similar to a Keurig machine. The pilot program, which ended earlier this year, is now under review by the state patrol, which plans to present its findings to state legislators.

Adageis was featured in a recent article that discussed how its ProActive Care approach shifts healthcare from reactive to preventive, patient-centered care by leveraging AI-driven analytics to identify high-risk patients and address care gaps. This model enhances patient outcomes by focusing on early intervention, care coordination, more time with doctors to focus on patient needs, and better overall health management. For healthcare providers, it boosts operational efficiency and revenue potential through optimizing workflows, meeting value-based care metrics, and minimizing administrative burdens. With the ability to integrate seamlessly with major electronic health record (“EHR”) systems, Adageis’ platform supports providers in delivering more personalized care, leading to better patient satisfaction and increased financial stability.

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company that is pioneering proprietary technology designed to attack solid tumors, empowering the immune system to combat cancer. The company was featured in a recent article that discussed its platform, which utilizes antitumor virotherapies that selectively infect and kill cancer cells while stimulating the body’s immune response. Calidi’s pipeline includes three key therapies — RTNova, SuperNova and NeuroNova — that incorporate advanced technologies such as stem cells and antitumor viruses to target and destroy cancer cells. Calidi Biotherapeutics’ innovative therapies hold the potential to revolutionize cancer treatment by enhancing efficacy and stimulating immune response. For cancers such as glioblastoma multiforme (“GBM”), head & neck, triple-negative breast cancer (“TNBC”), sarcoma and lung cancer, where current treatments are often inadequate, Calidi’s approach offers promising new potential.

Fifty 1 Labs (OTC: FITY), formerly Consumer Automotive Finance Inc. (OTC: CAFI), has successfully completed its name and ticker symbol change, now officially trading as FITY on the OTC market. This marks a significant milestone as the company continues executing its strategic growth initiatives. In addition, the company has responded to a second round of comments in its ongoing efforts to regain compliance with SEC Rule 15c2-11.

Upstream published a blog that discusses the financial world’s embracement of blockchain-powered trading. While many traditional stock markets operate on legacy infrastructure, Upstream is revolutionizing trading by leveraging blockchain technology to provide real-time execution, instant settlement, and global access without typical barriers. Unlike conventional stock markets that have longer settlement times and limited trading hours, Upstream allows investors to trade 20 hours a day, seven days a week, with instant transactions executed transparently on a decentralized ledger. Its platform offers a more accessible, efficient and fair trading experience, powering the future of stock trading today.